Physician profile
Carlos F Silva
NPI 1336213693
$5,264.85
in general payments reported to CMS, 2019-2025
25 companies · $1,172 in 2025
The $1,172 reported for 2025 was more than what 88% of Primary Podiatric Medicine providers received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,102 · 2020: $672 · 2021: $490 · 2022: $722 · 2023: $679 · 2024: $428 · 2025: $1,172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,279.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $1,017.08 | 2019-2022 | |
| Kerecis Limited | $558.40 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Abbott Laboratories | $508.46 | 2019-2025 | Diamondback Peripheral |
| Smith+Nephew, INC. | $500.15 | 2019-2025 | Collagenase Santyl, Oasis, Iodosorb Ointment 40g USA |
| Orthofix Medical, INC. | $323.09 | 2020-2025 | Physio-Stim |
| Paratek Pharmaceuticals, INC. | $291.34 | 2021-2025 | Nuzyra |
| Organogenesis INC. | $234.96 | 2023-2025 | Affinity, Puraply |
| Cardiovascular Systems INC. | $206.09 | 2021-2022 | |
| Medtronic Vascular, INC. | $182.18 | 2019-2020 | |
| Melinta Therapeutics, LLC | $165.80 | 2019 | |
| Nevro Corp. | $144.44 | 2023 | Senza |
| Lifenet Health | $133.69 | 2025 | Theragenesis Wound Matrix |
| Amgen INC. | $125.00 | 2025 | Krystexxa |
| Abbvie INC. | $122.19 | 2022 | |
| Averitas Pharma INC. | $111.05 | 2023 | Qutenza |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $104.09 | 2022 | |
| Bioventus LLC | $101.09 | 2025 | Exogen Ultrasound Bone Healing System |
| Convatec INC. | $96.66 | 2024 | |
| Stability Biologics, LLC | $85.47 | 2022 | |
| Medtronic, INC. | $82.89 | 2023 | Hawkone |
| Allergan, INC. | $67.13 | 2020 | |
| Sandoz INC. | $42.64 | 2020-2021 | |
| Novum Pharma, LLC | $24.17 | 2019 | |
| Mimedx Group, INC. | $24.01 | 2025 | |
| Mayne Pharma Commercial LLC | $12.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Silva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.